Clinical trials in T-Cell lymphoma

The list below shows The Lymphoma Group's current clinical trials open for recruitment for T-Cell lymphoma patients.

If you would like to know how to access our trials, please see how to contact us.

• PROCLIPI – A non-medicinal (observational) clinical trial involving collecting data on patients with mycosis fungoides (primary cutaneous T cell lymphoma) and Sézary syndrome (SS), to help determine how we manage future patients.A non-medicinal (observational) clinical trial involving collecting data on patients with mycosis fungoides (primary cutaneous T cell lymphoma) and Sézary syndrome (SS), to help determine how we manage future patients.
• StepPharma/STP938 – Testing STP938 in people with T-cell and B-cell lymphomas that has relapsed or is refractory
• BioInvent – Testing a treatment called BI-1808 with or without Pembrolizumab in people with T cell lymphoma
• SGN35C-001 – A phase 1 trial of SGN-35C in patients with relapsed or refractory lymphoma

With special thanks to the following:

For further information on each trial, please visit the Find a trial page on Lymphoma Action’s website.